U.S. Health Strategy Group

Commercialization strategy for medical technology entering the U.S. market.

Choose where to enter, resolve launch barriers and test demand before committing to expansion. Get a clear recommendation and a practical plan for your medical technology.

For U.S. and international companies entering, relaunching or expanding in the United States.

Relevant marketsNeuromodulation & painRehabilitation & clinical workflowConnected devices & digital healthFederal & institutional channels

Advisory portfolio

What does your team need to decide?

Find the advisory support and deliverables for your next decision.

Market Entry StrategyChoose your first U.S. customers and route to market.

Priority market and account map, market-entry recommendation and launch roadmap.

Explore this service
Regulatory & Market AccessKnow what must be resolved before a viable U.S. launch.

Product and evidence gap assessment, coverage, coding and payment assessment and readiness action plan.

Explore this service
Clinical Adoption & PilotsPlan how clinicians will adopt and use your technology.

Site implementation plan, pilot measurement plan and research and education workplan.

Explore this service
Commercial Launch PlanningGive your team a practical plan to launch and grow.

Sales and territory plan, channel and operating handoff and management and decision plan.

Explore this service
KOL & Expert AdvisoryTurn specialist input into recommendations your team can use.

Expert selection map, advisory assignment briefs and written findings and recommendations.

Explore this service

Choose the level of engagement

Choose the support your next stage needs.

Resolve a question, build a plan, coordinate a launch or retain ongoing advisory.

Pilot-first validation

Test demand. Set the conditions for expansion.

A bounded pilot can evaluate account strategy, clinical workflow, specialist support, operating dependencies and expansion criteria before broader hiring, inventory or exclusivity commitments.

DEFINE

Objective, geography, accounts, roles and decision criteria.

RUN

Weekly operating cadence and measurable field activity.

DECIDE

Go, change or stop recommendation based on evidence and economics.

Operating network

Connect strategy with the partners who execute it.

USHSG leads its contracted advisory scope. Product operations, certification, distribution, logistics and procurement execution remain with the organization authorized for that work.

Distribution platform

U.S. Distribution Group LLC

National distribution-network structure for participating operating companies and partners, including federal procurement, supply chain, logistics and 3PL capabilities.

Distribution platform

First operating company

Northwest MedTech LLC

Medical-device sales, agency, contracting and product-specific execution within the U.S. Distribution Group network, with a focused role in neuromodulation and selected device categories.

Northwest MedTech

Certification resource

Ente Certificazione Macchine (ECM)

A certification resource considered when designation and technical scope match the device and requested work. Certification decisions remain with the qualified body.

Certification support

Founder-led advisory

Commercial experience. Expertise matched to the assignment.

Dylan Gaar leads client strategy, commercial planning and partner coordination. Clinical, reimbursement, research, operational and technical specialists are engaged by scope when the assignment requires them.

About the firm

Selected experience

Greenfield market development, multi-state commercial leadership and medical-device commercialization.

Experience includes Oregon market development at Zynex, regional and multi-state leadership at Upstream Rehabilitation, and medical-device commercialization in neuromodulation and institutional markets.

How expert advisory works

Next step

Define your next commercial move.

Get a recommendation on project fit, priorities and scope.

Request a project discussion